Labcorp Holdings Inc. (LH) Free Cash Flow CAGR:20.14%(TTM)
Free cash flow CAGR uses precomputed cash-flow statement history.
Over longer horizons, Labcorp Holdings Inc.'s Free Cash Flow CAGR averages 3.11% over 3 years and -12.63% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Free cash flow CAGR measures how Labcorp Holdings Inc.'s cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
LH Free Cash Flow CAGR Chart
Labcorp Holdings Inc. (LH)
LH Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
LH Free Cash Flow CAGR History
| Year | Start FCF | End FCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $1.10B | $1.21B | +$110.10M | +10.05% | +10.05% |
| 2024 | $874.10M | $1.10B | +$221.80M | +25.37% | +25.37% |
| 2023 | $1.47B | $874.10M | $-599.90M | -40.70% | -40.70% |
| 2022 | $2.65B | $1.47B | $-1.18B | -44.36% | -44.36% |
| 2021 | $1.75B | $2.65B | +$895.60M | +51.07% | +51.07% |
| 2020 | $1.04B | $1.75B | +$709.10M | +67.89% | +67.89% |
| 2019 | $925.60M | $1.04B | +$118.90M | +12.85% | +12.85% |
| 2018 | $1.14B | $925.60M | $-218.40M | -19.09% | -19.09% |
| 2017 | $897.00M | $1.14B | +$247.00M | +27.54% | +27.54% |
| 2016 | $726.60M | $897.00M | +$170.40M | +23.45% | +23.45% |
| 2015 | $535.50M | $726.60M | +$191.10M | +35.69% | +35.69% |
| 2014 | $616.50M | $535.50M | $-81.00M | -13.14% | -13.14% |
| 2013 | $665.10M | $616.50M | $-48.60M | -7.31% | -7.31% |
| 2012 | $709.90M | $665.10M | $-44.80M | -6.31% | -6.31% |
| 2011 | $757.10M | $709.90M | $-47.20M | -6.23% | -6.23% |
| 2010 | $747.70M | $757.10M | +$9.40M | +1.26% | +1.26% |
| 2009 | $624.20M | $747.70M | +$123.50M | +19.79% | +19.79% |
| 2008 | $566.40M | $624.20M | +$57.80M | +10.20% | +10.20% |
| 2007 | $515.80M | $566.40M | +$50.60M | +9.81% | +9.81% |
| 2006 | $480.60M | $515.80M | +$35.20M | +7.32% | +7.32% |
| 2005 | $443.10M | $480.60M | +$37.50M | +8.46% | +8.46% |
| 2004 | $480.70M | $443.10M | $-37.60M | -7.82% | -7.82% |
| 2003 | $370.60M | $480.70M | +$110.10M | +29.71% | +29.71% |
| 2002 | $227.90M | $370.60M | +$142.70M | +62.62% | +62.62% |
| 2001 | $191.20M | $227.90M | +$36.70M | +19.19% | +19.19% |
| 2000 | $111.10M | $191.20M | +$80.10M | +72.10% | +72.10% |
| 1999 | $42.70M | $111.10M | +$68.40M | +160.19% | +160.19% |
| 1998 | $109.90M | $42.70M | $-67.20M | -61.15% | -61.15% |
| 1997 | $-240.90M | $109.90M | +$350.80M | N/A | N/A |
Quarterly Free Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $70.50M | -85.6% | — |
| Q4 2025 | $490.30M | +74.8% | -26.3% |
| Q3 2025 | $280.50M | -48.3% | +73.7% |
| Q2 2025 | $542.70M | — | +25.4% |
| Q1 2025 | -$107.50M | — | +34.3% |
| Q4 2024 | $665.10M | +311.8% | +61.3% |
| Q3 2024 | $161.50M | -62.7% | -5.3% |
| Q2 2024 | $432.90M | — | +82.0% |
| Q1 2024 | -$163.60M | — | — |
| Q4 2023 | $412.40M | +141.7% | -23.0% |
| Q3 2023 | $170.60M | -28.3% | -36.9% |
| Q2 2023 | $237.80M | +771.1% | -44.6% |
| Q1 2023 | $27.30M | -94.9% | -88.6% |
| Q4 2022 | $535.70M | +98.2% | -2.2% |
| Q3 2022 | $270.30M | -37.0% | -58.4% |
| Q2 2022 | $429.20M | +79.7% | +10.1% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter